[人乳头瘤病毒疫苗预防和治疗呼吸道乳头状瘤病的研究现状]
[Research status of human papillomavirus vaccine for prevention and treatment of respiratory papillomatosis].
作者信息
Pan X F, Wang J, Xiao Y
出版信息
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Feb 5;33(2):189-192. doi: 10.13201/j.issn.1001-1781.2019.02.025.
Abstract
Recurrent respiratory papilloma (RRP) is closely related to human papillomavirus (HPV) infection and is the main pathogenic factor. At present, HPV vaccine injection is a new method to control RRP, and its efficacy has been confirmed by many clinical trials. The development and application of HPV vaccine is bound to bring new development to the treatment of RRP. This article reviews the status of HPV vaccine in clinical RRP treatment.
摘要
复发性呼吸道乳头状瘤（RRP）与人类乳头瘤病毒（HPV）感染密切相关，是主要致病因素。目前，注射HPV疫苗是控制RRP的一种新方法，其疗效已得到多项临床试验证实。HPV疫苗的研发和应用必将给RRP的治疗带来新的发展。本文综述了HPV疫苗在RRP临床治疗中的现状。
Zotero 插件